Help
RSS
API
Feed
Maltego
Contact
Domain > mail.piterasaki.org
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2026-03-05
173.201.184.188
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Thu, 03 Apr 2025 04:25:58 GMTServer: ApacheUpgrade: h2,h2cConnection: UpgradeLast-Modified: Tue, 13 Feb 2024 21:01:44 GMTETag: 2761ffe-76c-61149b3ac5934Accept-Ranges: bytesContent !DOCTYPE html PUBLIC -//W3C//DTD HTML 4.01 Transitional//EN>html> head> meta http-equivcontent-type contenttext/html; charsetUTF-8> title>/title> /head> body> font size+1>b>Paul I Terasaki Research Fund/b>/font>br> br> a moz-do-not-sendtrue hrefbkg.html>Paul I. Terasaki/a>br> br> a moz-do-not-sendtrue hrefhistory.html>Fund history/a> br> br> a moz-do-not-sendtrue hreffund.html>Fund details/a>br> br> br> b>i>Recent News/i>/b> br> br> February, 2024 -- Two papers published this month! in a moz-do-not-sendtrue hrefNong24.pdf>i>Transplantation/i>/a> and a moz-do-not-sendtrue hrefShih24.pdf>i>Nature Communications/i>/a>br> br> July, 2023 -- Dr. Anat Tambur awarded an R01 NIH grant! The grant proposal, The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation, is based on work supported by a previous grant from the Paul I Terasaki Research Fund. br> br> June 3, 2023 -- The first paper from the Terasaki Innovation Center is accepted! It will be published in the journal i>Transplantation/i>.br> Stable Expression of novel DQβ:DRα Heterodimers on the surface of lymphoblastoid and transfected cell lines. Thoa Nong, Remi Shih, Robert A. Bray, Mayra Lopez-Cepero, Cathi Murphey, Peter W. Nickerson and Jar-How Lee. br> br> March, 2023 -- One Lambda will renew 3 year support of the Terasaki Innovation Center, beginning January 1, 2024. br> br> January, 2023 -- The passing of a moz-do-not-sendtrue hrefhttps://jitc.bmj.com/content/11/1/e006761>Dr. Soldano Ferrone/a> from Covid in January. He had a major role in starting this fund.br> /body>/html>
Port 443
HTTP/1.1 200 OKDate: Thu, 03 Apr 2025 04:25:58 GMTServer: ApacheUpgrade: h2,h2cConnection: UpgradeLast-Modified: Tue, 13 Feb 2024 21:01:44 GMTETag: 2761ffe-76c-61149b3ac5934Accept-Ranges: bytesContent !DOCTYPE html PUBLIC -//W3C//DTD HTML 4.01 Transitional//EN>html> head> meta http-equivcontent-type contenttext/html; charsetUTF-8> title>/title> /head> body> font size+1>b>Paul I Terasaki Research Fund/b>/font>br> br> a moz-do-not-sendtrue hrefbkg.html>Paul I. Terasaki/a>br> br> a moz-do-not-sendtrue hrefhistory.html>Fund history/a> br> br> a moz-do-not-sendtrue hreffund.html>Fund details/a>br> br> br> b>i>Recent News/i>/b> br> br> February, 2024 -- Two papers published this month! in a moz-do-not-sendtrue hrefNong24.pdf>i>Transplantation/i>/a> and a moz-do-not-sendtrue hrefShih24.pdf>i>Nature Communications/i>/a>br> br> July, 2023 -- Dr. Anat Tambur awarded an R01 NIH grant! The grant proposal, The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation, is based on work supported by a previous grant from the Paul I Terasaki Research Fund. br> br> June 3, 2023 -- The first paper from the Terasaki Innovation Center is accepted! It will be published in the journal i>Transplantation/i>.br> Stable Expression of novel DQβ:DRα Heterodimers on the surface of lymphoblastoid and transfected cell lines. Thoa Nong, Remi Shih, Robert A. Bray, Mayra Lopez-Cepero, Cathi Murphey, Peter W. Nickerson and Jar-How Lee. br> br> March, 2023 -- One Lambda will renew 3 year support of the Terasaki Innovation Center, beginning January 1, 2024. br> br> January, 2023 -- The passing of a moz-do-not-sendtrue hrefhttps://jitc.bmj.com/content/11/1/e006761>Dr. Soldano Ferrone/a> from Covid in January. He had a major role in starting this fund.br> /body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]